NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering

Rhea-AI Summary

NCS Multistage Holdings (NASDAQ:NCSM) has announced the acquisition of ResMetrics LLC, a leading provider of chemical tracer diagnostics services for the oil and gas industry. The strategic acquisition enhances NCS's tracer diagnostics capabilities and expands their service offering for well optimization and reservoir development.

ResMetrics specializes in chemical tracer technologies that help operators validate reservoir strategies, improve fracture designs, evaluate well connectivity, and optimize oil recovery programs. The company operates primarily in the United States, UAE, and Kuwait. The acquisition details will be discussed during NCS's Q2 earnings call on August 1, 2025.

Positive

• Strategic expansion of NCS's tracer diagnostics capabilities
• Access to ResMetrics' state-of-the-art analytical laboratory and quality control systems
• Geographic expansion into UAE and Kuwait markets
• Enhanced service offering for well optimization and reservoir development

Negative

• Financial terms of the acquisition not disclosed
• Integration costs and challenges may impact short-term performance

Insights

Oil & Gas Industry Analyst

NCS Multistage's acquisition of ResMetrics strengthens its tracer diagnostics portfolio, creating synergistic value in oil field services.

NCS Multistage's acquisition of ResMetrics represents a strategic expansion of its tracer diagnostics capabilities in the oil and gas services sector. This transaction combines complementary technologies that will enhance NCS's ability to provide critical reservoir analysis services to energy producers.

The acquisition targets a specialized niche within oil field services—chemical tracer diagnostics—which helps operators optimize well performance through better understanding of reservoir characteristics, fracture networks, and fluid movement. These diagnostic tools are particularly valuable in unconventional resource development where precise fracture design and well spacing decisions directly impact economic returns.

ResMetrics brings established expertise in chemical tracer technologies that will integrate with NCS's existing service portfolio. The combined offering will provide more comprehensive reservoir insights, allowing customers to validate development strategies, improve stimulation designs, evaluate inter-well connectivity, and optimize enhanced oil recovery programs—all critical factors in maximizing production efficiency and financial returns.

This transaction appears to follow a logical consolidation trend in oil field services, where companies seek to broaden technical capabilities while maintaining specialized expertise. The involvement of CSL Capital Management as a backer of ResMetrics suggests the acquired company had strong financial support during its development phase, potentially indicating a well-established operational foundation and customer base.

The acquisition timing coincides with industry focus on operational efficiency and capital discipline, as operators increasingly rely on diagnostic technologies to maximize returns from existing assets rather than pursuing aggressive new drilling programs.

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (“NCS” or the “Company”) today announced that it has acquired ResMetrics LLC (“ResMetrics”), a leading provider of chemical tracer diagnostics services used by oil and gas operators to validate reservoir development strategies, improve hydraulic fracture stimulation designs, evaluate inter-well connectivity, and optimize enhanced oil recovery injection programs, complementing and further strengthening NCS’s tracer diagnostics capabilities.

“I am excited to welcome the ResMetrics team to NCS,” said Ryan Hummer, NCS’s Chief Executive Officer. “ResMetrics brings trusted chemical tracer technologies that complement our existing capabilities, enhancing our ability to deliver actionable insights that help customers maximize well performance and financial returns.”

“ResMetrics has built a strong reputation for delivering high quality and reliable tracer diagnostics services to our customers,” said Sharad Behal, Chief Executive Officer of ResMetrics. “We expect that joining together with NCS will accelerate our growth and increase the breadth of diagnostics and other solutions available to our customers.”

ResMetrics was built in conjunction with CSL Capital Management. Charlie Leykum, Founding Partner and CEO of CSL, expressed his admiration for the achievements of the ResMetrics team, stating, “I am incredibly proud of the dedication and innovation demonstrated by ResMetrics since its founding. Their commitment to advancing tracer diagnostics and delivering value to customers has solidified their leadership position in the industry. We are excited to see ResMetrics enter this next chapter with NCS and look forward to all that the future holds for the company and its talented team.”

Shook, Hardy and Bacon L.L.P. served as legal advisor to NCS. Piper Sandler acted as exclusive financial advisor and Winston Strawn LLP served as legal advisor to ResMetrics.

NCS will provide additional details on the ResMetrics acquisition during its second quarter earnings conference call scheduled for August 1, 2025.

NCS Multistage Holdings, Inc. is a leading provider of highly engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides products and services primarily to exploration and production companies for use in onshore and offshore wells, predominantly wells that have been drilled with horizontal laterals in both unconventional and conventional oil and natural gas formations. NCS’s products and services are utilized in oil and natural gas basins throughout North America and in selected international markets, including the North Sea, the Middle East, Argentina and China. NCS’s common stock is traded on the Nasdaq Capital Market under the symbol “NCSM.” Additional information is available on the website, www.ncsmultistage.com.

ResMetrics, LLC is a leading provider of oilfield tracer services, leveraging robust quality control systems and its state-of-the-art analytical laboratory to ensure accurate results. ResMetrics provides its customers with valuable data to assess and improve completion designs and to efficiently optimize reservoir development and production, including in enhanced oil recovery and high-temperature applications. ResMetrics provides its services primarily in the United States, the UAE and Kuwait.

Contact:
Mike Morrison
Chief Financial Officer and Treasurer
+1 281-453-2222
IR@ncsmultistage.com

FAQ

What company did NCS Multistage (NCSM) acquire in July 2025?

NCS Multistage acquired ResMetrics LLC, a leading provider of chemical tracer diagnostics services for the oil and gas industry.

What services does ResMetrics provide to oil and gas operators?

ResMetrics provides chemical tracer diagnostics services to validate reservoir development strategies, improve hydraulic fracture stimulation designs, evaluate inter-well connectivity, and optimize enhanced oil recovery injection programs.

Where does ResMetrics operate its services?

ResMetrics primarily operates in the United States, UAE, and Kuwait, providing tracer services through its state-of-the-art analytical laboratory.

When will NCS Multistage provide more details about the ResMetrics acquisition?

NCS will provide additional details about the ResMetrics acquisition during its second quarter earnings conference call on August 1, 2025.

How will the ResMetrics acquisition benefit NCS Multistage?

The acquisition will enhance NCS's tracer diagnostics capabilities, expand their geographic presence, and increase their ability to deliver actionable insights for customer well performance and financial returns optimization.